Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line.

MLA

Liu, Qun, et al. “Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line.” Biomedicines, vol. 11, no. 1, Jan. 2023, p. 8. EBSCOhost, https://doi.org/10.3390/biomedicines11010008.

APA

Liu, Q., Tan, J., Zhao, Z., Li, R., Zheng, L., Chen, X., Li, L., Dong, X., Wen, T., & Liu, J. (2023). Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line. Biomedicines, 11(1), 8. https://doi.org/10.3390/biomedicines11010008

Chicago

Liu, Qun, Jingyu Tan, Zhenguo Zhao, Ruijun Li, Luyu Zheng, Xiangyu Chen, Lina Li, Xichen Dong, Tao Wen, and Jian Liu. 2023. “Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line.” Biomedicines 11 (1): 8. doi:10.3390/biomedicines11010008.